Avanos Medical (NYSE:AVNS – Get Free Report) and SS Innovations International (NASDAQ:SSII – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends.
Institutional and Insider Ownership
95.2% of Avanos Medical shares are held by institutional investors. 2.3% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings and target prices for Avanos Medical and SS Innovations International, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avanos Medical | 1 | 1 | 0 | 0 | 1.50 |
| SS Innovations International | 1 | 0 | 0 | 0 | 1.00 |
SS Innovations International has a consensus price target of $7.00, suggesting a potential upside of 418.52%. Given SS Innovations International’s higher probable upside, analysts plainly believe SS Innovations International is more favorable than Avanos Medical.
Earnings & Valuation
This table compares Avanos Medical and SS Innovations International”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Avanos Medical | $715.90 million | 1.64 | -$72.90 million | ($1.61) | -15.52 |
| SS Innovations International | $42.49 million | 6.37 | -$12.13 million | ($0.06) | -22.50 |
SS Innovations International has lower revenue, but higher earnings than Avanos Medical. SS Innovations International is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Avanos Medical and SS Innovations International’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avanos Medical | -10.39% | 5.39% | 3.97% |
| SS Innovations International | -23.73% | -26.77% | -15.01% |
Volatility and Risk
Avanos Medical has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500. Comparatively, SS Innovations International has a beta of -1.52, suggesting that its stock price is 252% less volatile than the S&P 500.
Summary
Avanos Medical beats SS Innovations International on 8 of the 12 factors compared between the two stocks.
About Avanos Medical
Avanos Medical, Inc. develops and markets medical devices and related products, with a focus on digestive health and pain management. Its offerings include enteral feeding tubes and delivery systems, as well as devices used in regional anesthesia and non-opioid pain management. The company’s products are used in hospitals, other health care facilities and home-care settings. Avanos serves customers in the United States and internationally. Avanos traces its history to Halyard Health, which became an independent company after separating from Kimberly-Clark in 2014.
About SS Innovations International
SS Innovations International is a medical technology company focused on developing and manufacturing surgical robotic systems. Its flagship product, the SSI Mantra, is a multi-arm platform designed to support surgeons during minimally invasive procedures. The company’s offerings include surgical instruments and related technologies, such as its SSI Mudra instruments, as well as training and support services for hospitals and clinicians. The SSI Mantra system is designed with features including a surgeon console and 3D visualization, and the company has also emphasized remote surgery and telementoring capabilities.
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.
